| Heterotrophic plate counts and drinking-water safety J Bartram, JA Cotruvo, M Exner, C Fricker, A Glasmacher IWA publishing, 2003 | 558* | 2003 |
| Bisphosphonates in multiple myeloma: a network meta‐analysis R Mhaskar, J Redzepovic, K Wheatley, OAC Clark, B Miladinovic, ... Cochrane Database of Systematic Reviews, 2012 | 539* | 2012 |
| Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy H Pels, IGH Schmidt-Wolf, A Glasmacher, H Schulz, A Engert, V Diehl, ... Journal of Clinical Oncology 21 (24), 4489-4495, 2003 | 475 | 2003 |
| A systematic review of phase‐II trials of thalidomide monotherapy in patients with relapsed or refractory multiple myeloma A Glasmacher, C Hahn, F Hoffmann, R Naumann, H Goldschmidt, ... British journal of haematology 132 (5), 584-593, 2006 | 352 | 2006 |
| Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients A Glasmacher, A Prentice, M Gorschlüter, S Engelhart, C Hahn, ... Journal of Clinical Oncology 21 (24), 4615-4626, 2003 | 339 | 2003 |
| Neutropenic enterocolitis in adults: systematic analysis of evidence quality M Gorschlüter, U Mey, J Strehl, C Ziske, M Schepke, IGH Schmidt‐Wolf, ... European journal of haematology 75 (1), 1-13, 2005 | 327 | 2005 |
| Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid … RF Schlenk, K Döhner, S Mack, M Stoppel, F Király, K Götze, F Hartmann, ... Journal of Clinical Oncology 28 (30), 4642-4648, 2010 | 285 | 2010 |
| Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem‐cell transplantation DI Marks, A Pagliuca, CC Kibbler, A Glasmacher, CP Heussel, M Kantecki, ... British journal of haematology 155 (3), 318-327, 2011 | 282 | 2011 |
| Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis J Maertens, A Glasmacher, R Herbrecht, A Thiebaut, C Cordonnier, ... Cancer 107 (12), 2888-2897, 2006 | 256 | 2006 |
| Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein M von Lilienfeld-Toal, MP Dietrich, A Glasmacher, L Lehmann, P Breig, ... European Journal of Clinical Microbiology and Infectious Diseases 23, 539-544, 2004 | 234 | 2004 |
| Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia RF Schlenk, S Fröhling, F Hartmann, JT Fischer, A Glasmacher, ... Leukemia 18 (11), 1798-1803, 2004 | 216 | 2004 |
| Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine C Ziske, C Schlie, M Gorschlüter, A Glasmacher, U Mey, J Strehl, ... British journal of cancer 89 (8), 1413-1417, 2003 | 207 | 2003 |
| Clostridium difficile Infection in Patients with Neutropenia M Gorschlüter, A Glasmacher, C Hahn, F Schakowski, C Ziske, E Molitor, ... Clinical Infectious Diseases 33 (6), 786-791, 2001 | 204 | 2001 |
| Making sense of itraconazole pharmacokinetics AG Prentice, A Glasmacher Journal of Antimicrobial Chemotherapy 56 (suppl_1), i17-i22, 2005 | 183 | 2005 |
| Utility of a commercially available multiplex real-time PCR assay to detect bacterial and fungal pathogens in febrile neutropenia M von Lilienfeld-Toal, LE Lehmann, AD Raadts, C Hahn-Ast, KS Orlopp, ... Journal of clinical microbiology 47 (8), 2405-2410, 2009 | 178 | 2009 |
| Breakthrough invasive fungal infections in neutropenic patients after prophylaxis with itraconazole A Glasmacher, C Hahn, C Leutner, E Molitor, E Wardelmann, C Losem, ... Mycoses 42 (7‐8), 443-451, 1999 | 176 | 1999 |
| Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul‐Ehrlich‐Society for Chemotherapy M Ruhnke, V Rickerts, OA Cornely, D Buchheidt, A Glöckner, W Heinz, ... Mycoses 54 (4), 279-310, 2011 | 174 | 2011 |
| Enhanced lytic activity of cytokine-induced killer cells against multiple myeloma cells after co-culture with idiotype-pulsed dendritic cells A Marten, S Renoth, M VON Lilienfeld-Toal, P Buttgereit, F Schakowski, ... Haematologica 86 (10), 1029-1037, 2001 | 174 | 2001 |
| Clinical pharmacology of antifungal compounds AH Groll, JC Gea-Banacloche, A Glasmacher, G Just-Nuebling, ... Infectious Disease Clinics 17 (1), 159-191, 2003 | 173 | 2003 |
| Lenalidomide, adriamycin, and dexamethasone (RAD) in patients with relapsed and refractory multiple myeloma: a report from the German Myeloma Study Group DSMM (Deutsche … S Knop, C Gerecke, P Liebisch, MS Topp, U Platzbecker, O Sezer, ... Blood, The Journal of the American Society of Hematology 113 (18), 4137-4143, 2009 | 171 | 2009 |
Tilman SauerbruchProfessor emeritus在 uni-bonn.de 的电子邮件经过验证
